Cryoablation of Typical Atrioventricular Nodal Reentrant Tachycardia in Children: Six Years’ Experience and Follow‐Up in a Single Center

Background: Cryoablation is an effective and safe treatment for children with supraventricular tachycardias when the reentry circuit is located near the atrioventricular (AV) junction. We retrospectively reviewed consecutive cryoablation procedures for the treatment of atrioventricular nodal reentrant tachycardia (AVNRT) in children and young adults in a single pediatric center. Methods: From October 2002 to October 2008, cryoablation was attempted in 76 pediatric patients (mean age 11.3 ± 2.4 years, range: 6–16.4 years) with symptomatic typical AVNRT. Cryomapping, used to identify the tissue site for safe arrhythmia ablation, was performed at ?30°C for a maximum of 60 seconds. The efficacy of the cryomapping procedure was assessed in terms of disappearance of dual‐AV node physiology and noninducibility of AVNRT. Results: Cryoablations were from 4 to 8 minutes long at ?75°C. A single “bonus” cryoapplication (?75°C for minimum 6 minutes) was delivered to consolidate the acutely successful cryoablation for 64 consecutive patients. After the cryoablation procedure, patients were assessed at 1, 3, 6, 12, 18, and 24 months (and then every year thereafter) by a clinical evaluation and standard electrocardiogram, Holter monitoring, and exercise stress testing. No permanent cryo‐related complications were reported. Seventy‐four (97.4%) patients were successfully acutely ablated. During a mean follow‐up of 29.5 months (range 2–74 months), five (6.8%) acutely successful pediatric patients experienced arrhythmia recurrence. We did not identify any predictive factors of AVNRT recurrence. Conclusions: Acute and long‐term results demonstrate that cryoablation of AVNRT can be considered a safe and effective procedure in pediatric patients. (PACE 2010; 475–481)     

Determination of Repetitive Slow Pathway Conduction for Evaluation of the Efficacy of Radiofrequency Ablation in AVNRT

LUKAC, P., et al.: Determination of Repetitive Slow Pathway Conduction for Evaluation of the Efficacy of Radiofrequency Ablation in AVNRT. Aims: To determine whether the loss of repetitive slow pathway conduction identifies a successful radiofrequency ablation of atrioventricular nodal reentry tachycardia (AVNRT). Methods and results: Thirty nine consecutive patients undergoing ablation of AVNRT using the slow pathway approach were included. At baseline and after each radiofrequency application with an episode of junctional rhythm, repetitive slow pathway conduction was assessed as follows: Effective refractory period of the fast pathway was determined. The coupling interval of the first atrial extrastimulus (A2) was set at 30 ms below the effective refractory period of the fast pathway to ensure its conduction via the slow pathway. The second atrial extrastimulus (A3) was introduced at progressively longer coupling intervals starting from 200 ms until: (1) it propagated to the His bundle or (2) an anterogradely blocked AV nodal echo of A2 appeared before a conducted A3 depolarized the atrium in the His bundle electrogram. The response was termed repetitive slow pathway conduction if A3 was conducted with an   AH > 200 ms   . Application was considered successful if no AVNRT could be induced. Repetitive slow pathway conduction was present after 1 of 39 successful and after 34 of 40 ineffective applications   (P < 0.0001)   . Repetitive slow pathway conduction identified a successful application with 97% sensitivity, 86% specificity, 86% positive predictive value, and 97% negative predictive value. Conclusion: The presence of repetitive slow pathway conduction identifies an unsuccessful application with a clinically meaningful negative predictive value. (PACE 2003; 26[Pt. I]:827–835)     

Linear Lesion Cryoablation for the Treatment of Atrioventricular Nodal Re‐entry Tachycardia in Pediatrics and Young Adults

Background: Radiofrequency (RF) ablation is a relatively safe and effective method for treatment of atrioventricular nodal re‐entry tachycardia (AVNRT), but carries a 1–2% risk of AV nodal injury. Cryothermal ablation reduces the risk of AV block, but has had decreased procedural success and increased recurrence of tachycardia. We sought to evaluate the technique of linear lesion cryoablation (LLC) for treatment of AVNRT. Methods: Single institution retrospective cohort study. Each patient underwent slow pathway modification using either RF, single lesion cryoablation, or LLC. Procedural success, recurrence, freedom from tachycardia 12 months following ablation and fluoroscopy time were compared between ablation methods. Results: A total of 125 patients, median age 15.5 (4.7–23.1) years, underwent ablation: 32 RF energy, 31 single lesion cryoablation, 62 LLC. Procedural success was obtained in 94% of the LLC group compared to 58% using single lesion cryoablation (P ≤ 0.001). Ninety‐seven percent of the LLC group was free from tachycardia recurrence, significantly higher than with single lesion cryoablation (68%, P = 0.001) and equal to that of RF (97%, P = NS). Fluoroscopy time was reduced in the LLC group compared to both single lesion and RF groups (P = 0.02). There was no permanent AV nodal injury in the cryoablation groups. Conclusion: LLC is an effective means of treatment for AVNRT and is associated with significantly improved procedural success and freedom from recurrence compared to single lesion methods, while at the same time obtaining equivalent efficacy to RF. (PACE 2010; 1304–1311)     

A Nodoventricular Fiber Associated with Dual AV Nodal Conduction, AV Nodal Reentrant Tachycardia, and Anterior Location of the Slow AV Nodal Pathway

We present a case of a patient with a nodoventricular tract, associated with dual AV nodal conduction and AV nodal reentrant tachycardia, and an anteroseptal location of the slow AV nodal pathway. The remarkable feature of this case is the site of successful ablation, in the anteroseptum just anterior and superior to the His bundle, where both preexcitation and dual AV nodal physiology were abolished.     

Radiofrequency Catheter Ablation for AV Nodal Reentry: A Technique for Rapid Transection of the Slow AV Nodal Pathway

Selective radiofrequency (RF) catheter ablation of the slow AV nodal puthway has shed new light on the anatomy and physiology of the atrioventricular junction. The recording of “slow pathway potentials” facilitates localization of the slow pathway and has led to a concept of multiple pathway components with atrial insertion sites covering a potentially broad region surrounding the coronary sinus os. The critical area for complete interruption of the slow pathway may be larger than lesion size produced by ablation at a single site, resulting in multiple RF applications with lengthy sessions and prolonged radiation exposure. Information from both old and recent literature suggests that the slow AV nodal pathway is represented by a group of fibers originating from the posteroinferior interatrial septum and coursing anterosuperiorly near the tricuspid annulus before converging upon the compact AV node. Based on this anatomical arrangement, the present study was conducted to evaluate a technique designed to transect the slow pathway by producing a linear RF lesion perpendicular to the orientation of the slow pathway within the mid-portion of Koch's triangle. Using this technique, 30 of 30 patients with common AV nodal reentry ivere rendered noninducible using 1 to 3 RF applications. Total procedure time averaged 3.4 ± 1.1 hours and fluoroscopy time averaged 14.8 ± 4.6 minutes. As a marker of efficacy, episodic nonsustained atrial tachycardia (NSAT) during RF delivery occurred in 28 of 30 (93%) successful applications. Three patients experienced tachycardia recurrence and were successfully ablated by repeat procedure. Conduction characteristics and refractoriness of the fast pathway were unchanged in 23 of 23 patients reevaluated at a mean of 7.2 weeks postablation. Two of 30 (6%) patients experienced procedure related complications but there were no instances of AV block. We conclude that the technique of producing a linear lesion by continuous migratory RF application in the manner described safely and effectively eliminates AV nodal reentry, simplifies the procedure, and minimizes radiation exposure to the patient and the physician.     

Fulguration for AV Nodal Tachycardia: Results in 42 Patients with a Mean Follow-Up of 23 Months

HAISAGUERRE, M., ET AL.: Fulguration for AV Nodal Tachycardia: Results in 42 Patients with a Mean Follow-Up of 23 Months. This report describes a catheter ablation technique to treat atrioventricular nodal reentrant tachycardia while preserving anterograde conduction, and its application in 42 patients with drug-refractory repetitive episodes of tachycardia. One of these patients had common and reverse forms of tachycardia. Using atrial activation in the His-bundle lead as a reference, the optimal ablation site was selected by positioning an electrode catheter to obtain a synchronous or earlier atrial activation than the reference during tachycardia. At this site, His-bundle deflection was completely absent, or was present at a low amplitude (< 0.1 mV). In the majority of patients, these criteria were found in the immediate vicinity of the site of proximal His-bundle recording (adjacent to the reference catheter). Shocks of 160 or 240 joules (J) were delivered at this site (mean ± SD = 518 ± 392 J/session) with a resulting preferential abolition of impairment of fast retrograde conduction. Anterograde conduction, though modified, was preserved in all patients, except for four (10%) patients who remained in complete heart block. Thirty patients (70%) remained free of arrhythmia without medication or pacemaker for a mean follow-up period of 23 ± 13 (2–63) months. Six other patients (15%) were controlled with a previously ineffective medication.     

Treatment of left-sided extension of AV node: A valuable integration of advance imaging modalities and cryoablation

We present a case of successful cryoablation of the left extension of the atrioventricular (AV) node for treatment of a recurrent atrioventricular nodal reentry tachycardia without the use of fluoroscopy. Three-dimensional electroanatomic mapping system and intracardiac echocardiography were used to navigate catheters in the heart and position them according to anatomical landmarks. Due to the nature of cryoablation lesion formation, lesions were able to be applied safely in right atrium, as well as in left atrium, without damaging AV node or bundle of His.     

Coincident Idiopathic Left Ventricular Tachycardia and Atrioventricular Nodal Reentrant Tachycardia: Control by Radiofrequency Catheter Ablation of the Slow Atrioventricular Nodal Pathway

A healthy 37-year-old male presented with a history of frequent palpitations and sustained wide QRS complex tachycardia with a right bundle branch block and left axis morphology. Serial electrophysiological studies revealed two inducible tachycardias, which were shown to represent atrioventricular nodal reentrant tachycardia and idiopathic left ventricular tachycardia. Transformation from one tachycardia to the other occurred spontaneously as well as following atrial or ventricular pacing. Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia. The patient has remained asymptomatic without antiarrhythmic therapy for 8 months.     

Changes in AV Node Conduction Curves Following Slow Pathway Modification

GELLER, J.C., et al. : Changes in AV Node Conduction Curves Following Slow Pathway Modification. Dual AV node physiology often persists after successful slow pathway (SP) ablation, and the mechanism of tachycardia elimination is unresolved. Therefore, AV node conduction curves were analyzed following successful ablation (  4 ± 1  energy applications) in 85 consecutive patients (58 women, age  50 ± 2  years) with typical AVNRT. Twenty-seven patients (32%) had complete elimination (group 1) whereas 58 (68%) patients had persistence (group 2) of dual AV node physiology. A significant increase in the AV node Wenckebach cycle length (WB-CL) was observed in both groups (  310 ± 9 to 351 ± 15 ms  in group 1, and  325 ± 8 to 369 ± 9 ms  in group  2, P < 0.05  ). A decrease in the fast pathway (FP) ERP (  339 ± 15 to 279 ± 12 ms  ) and an increase in the maximum FP AH interval (  141 ± 5 to 171 ± 7  ) were observed only in group 1 (P < 0.05). In group 2, no change in the SP ERP (  267 ± 7 to 280 ± 10 ms  ) was observed, and the change in the maximum SP-AH following ablation showed a significant inverse relation to the maximum SP-AH at baseline in group 2. In conclusion, (1) an increase in the WB-CL is observed independent of the persistence or elimination of dual physiology after successful ablation; (2) when dual physiology is eliminated, significant changes in the FP ERP and the maximum FP-AH occur; (3) when dual physiology persists, FP physiology and the SP ERP remain unchanged, and a significant inverse relation between the change in the maximum SP-AH following ablation and the maximum baseline SP-AH is observed.     

Modification of Atrioventricular Conduction by Selective AV Nodal Artery Catheterization

The effects of selective AV nodal artery embolization on AV nodal function was investigated in six closed-chest adult dogs. Programmed atrial stimulation was performed to determine control values for AV nodal effective refractory period (AVN-ERP) and the paced cycle length at which AV nodal Wenckebach conduction occurred (WCL). Using standard percutaneous femoral techniques of coronary artery catheterization, a flexible infusion catheter was positioned selectively in the AV nodal artery. Proper positioning of the catheter was confirmed angiographically and by selective acetylcholine (ACH) infusion into the AV nodal artery, which caused transient complete AV nodal block in three dogs, and for the group, caused lengthening of both AVN-ERP and WCL. Following cessation of ACH infusion and autonomic blockade with atropine 0.04 mg/kg and propranolol 0.2 mg/kg, denervated recontrol values for AVN-ERP and WCL were 192 msec and 243 msec, respectively. The AV nodal artery was then embolized with a suspension of cross-linked collagen fibrils in either normal saline or absolute ethanol. Successful embolization of the AV nodal artery, confirmed angiographically, caused an acute increase in AVN-ERP (243 msec, P less than 0.05 compared to denervated control) and WCL (287 msec, P = 0.058 compared to denervated control). However, at a mean follow-up of 37 days, only one animal exhibited a chronic increase in AVN-ERP and WCL. Selective AV nodal artery catheterization can be performed using standard percutaneous catheterization techniques. Selective administration of agents with direct cidal effects on the AV node using this technique may provide an alternative to conventional methods of catheter ablation of AV conduction in patients with drug-resistant supraventricular arrhythmias.     

Changes of the RR Interval and the QRS Morphology in AV Nodal Tachycardia: Further Evidence for Extranodal Involvement

A young patient wilh AV nodal tachycardia was referred for ablation. During electrophysiological testing, a stable succession of up to four different RR intervals with comcomitantly changing QRS morphologies were recorded. This observation might reflect the conduction of the reentry circuit through different extranodal "pathways" in the low right atrium. Radiofrequency current was applied near the ostium of the coronary sinus; this abolished conduction through the slow pathway, as dual AV conduction was no longer present. She remains free of recurrences for a follow-up period of 8 months.     

Wide QRS Tachycardia Due to AV Nodal Reentry and a "Bystander" Bypass Tract with Slow Conduction Properties

An unusual mechanism for recurrent, wide QRS complex supraventricular tachycardia is described in this report. A 25-year-old man with normal PR and QRS intervals during sinus rhythm was shown to have preexcitation with a left bundle branch block pattern during tachycardia and during atrial pacing. Electrophysiologic studies demonstrated slow and decremental conduction properties in an accessory "bystander" AV pathway utilized for antegrade conduction during AV nodal reciprocating tachycardia. The differential diagnosis of this tachycardia is discussed in detail.     

Successful Slow Pathway Ablation in a Patient with a Rare Unroofed Type Coronary Sinus

We report a case of atrioventricular nodal reentrant tachycardia coexistent with a coronary sinus (CS) anomaly. During a standard electrophysiological study, the CS could not be cannulated despite several attempts. A persistent left superior vena cava angiogram through the left brachial vein confirmed an unroofed type CS. Successful slow pathway ablation from the right posterior paraseptum lesion was achieved using an anatomical approach.     

Radiofrequency Catheter Ablation of Atrioventricular Nodal Reentrant Tachycardia in Children

Radiofrequency (RF) catheter ablation has been widely used in the treatment of cardiac arrhythmias. In atrioventricular nodal reentrant tachycardia (AVNRT), the experience has been predominantly in adults. The cardiac electrophysiological records of 18 consecutive children undergoing RF catheter AV node modification for AVNRT were reviewed. The patients (10 females, 8 males) were 8.2–17.9 years of age (mean 13.6 ± 3.0), weight 15.2–88.1 kg (mean 52.2 ± 20.8), and height 103–190 cm (mean 157.1 ± 21.7). Thirteen were on antiarrhythmic medications (1–3, average 1.5 drugs/day). All drugs were discontinued 48 hours prior to the ablations. The procedures were performed under sedation and local anesthesia. Pre- and post-AV node modification electrophysiological studies were performed in all procedures. The 18 patients underwent a total of 25 procedures (1.39 ± 0.61 per patient): the anterior approach aimed at the antegrade fast pathway in the first four patients and the posterior approach aimed at the slow pathway in the remainder. Thenumber of energy applications was 8–54 (19.8 ± 10.7) per procedure. The maximum energy used in each procedure was 30–50 watts (33.8 ± 8.4). The average energy was 24–50 watts (33.0 ± 6.8). The fluoroscopy time was 7.1–73.4 minutes (29.9 ± 20.0) per procedure, for a total catheterization time of 228–480 minutes (300.3 ± 59.1). Preablation spontaneous or induced AVNRT (cycle length 310.4 ± 55.0 msec) was seen in all except one who had the arrhythmia (cycle length 270 msec) on surface ECG. In 22 of 25 studies, the AH interval measured 67.4 ± 13.2 msec pre- and 98.7 ± 58.4 msec post-AV node modification (P < 0.02). Procedures were initially successful in 16 (89%) of 18 patients. One patient developed complete AV block requiring DDD pacemaker and has since recovered normal AV conduction. Transient third- or second-degree block was seen in four. Other complications included airway obstruction in one and excessive emesis in another. In follow-up of 2–26 months (13.0 ± 7.3), one patient underwent surgical ablation for failed initial RF catheter ablation, and two underwent successful RF procedures for recurrences. RF catheter AV node modification for AVNRT in children is a useful technique. Under ideal circumstances, it is safe and efficacious. Follow-up to determine the potential long-term complications is necessary.     

Radiofrequency Catheter Ablation of Atrioventricular Junctional ("AV Nodal") Reentrant Tachycardia in Patients with Implantable Cardioverter Defibrillators

Catheter ablation of tachycardias has been undertaken successfully in patients with ICDs without damage to the ICD or lead. Ablation of the slow AV nodal pathway, however, is technically challenging because the lead of the ICD lies close to the ablation site. We report successful ablation of AV Junctional reentrant tachycardia (AVJRT) in three patients with ICDs, In all cases, the ablation site was within a few millimeters of the ICD lead. The ablation was successful in all cases and did not cause damage to the ICD or lead. The patients have remained free of recurrence of AVJRT during a mean follow-up of 12 months.     

Specificity of Retrograde Conduction in Screening for Atrioventricular Nodal Reentrant Tachycardia

Baseline AV conduction properties (antegrade and retrograde) are often used to assess the presence of dual AV nodal physiology or concealed AV accessory pathways. Although retrograde conduction (RET) is assumed to be a prerequisite for AV nodal reentrant tachycardia (AVNRT), its prevalence during baseline measurements has not been evaluated. We reviewed all cases of AVNRT referred for radiofrequency ablation to determine the prevalence of RET at baseline evaluation and after isoproterenol infusion. Results: Seventy-three patients with AVNRT underwent full electrophysiological evaluation. Sixty-six patients had manifest RET and inducible AVNRT during baseline atrial and ventricular stimulation. Seven patients initially demonstrated complete RET block despite antegrade evidence of dual AV nodal physiology. In 3 of these 7 patients AVNRT was inducible at baseline despite the absence of RET. In the other four patients isoproterenol infusion was required for induction of AVNRT, however only 3 of these 4 patients developed RET. One of these remaining patients had persistent VA block after isoproterenol. Conclusions: The induction of AVNRT in the absence of RET suggests that this is not an obligatory feature of this arrhythmia. Therefore, baseline AV conduction properties are unreliable in assessing the presence of AVNRT and isoproterenol infusions should be used routinely to expose RET and reentrant tachycardia.     

Slow AV Nodal Pathway Ablation Utilizing a Unique Temperature Controlled Radiofrequency Energy System

Thirty-nine consecutive patients with symptomatic AV nodal reentrant tachycardia (AVNRT) underwent temperature guided slow AV nodal pathway ablation (group 1). Forty-three consecutive patients undergoing nontemperature guided slow AV nodal pathway ablation late in our experience compose the control population (group 2). Slow pathway ablation was achieved in all patients of both groups. The mean fluoroscopy and ablation times for group 1 were significantly shorter than for group 2 (26.1 ± 14.9 vs 33.9 ± 18.9 min, P < 0.05; 19.9 ± 12.1 vs 30.9 ± 23.3 min, P ≤ 0.02). There were no episodes of coagulum formation in group 1, while there were 15 episodes (7.1 % of energy applications) in group 2 (P = 0.0006) despite a significantly higher applied power in group 1 (53.4 ± 25.1 vs 35.6 ± 9.5W, P = 0.0001). Successful energy applications were associated with significantly higher temperatures than unsuccessful applications in group 1 (55.6 ± 5.8 C vs. 52.9 ± 6.8 C, P ≤ 0.03). The minimum temperature required for successful ablation was 48 C for two patients (5%) and was > 50 C for the remainder of patients (37/39 [95%]). The catheter ablation system used in this study was safe, effective, and prevented coagulum formation while delivering relatively high power. In addition, shorter ablation times and radiation exposure were seen with this system. Although successful energy applications and the production of junctional rhythm were associated with higher achieved temperatures, temperature alone did not predict either endpoint. Future prospective, randomized trials are needed to confirm these findings and further evaluate the value of temperature monitoring.